K. De Boeck

649 total citations
10 papers, 454 citations indexed

About

K. De Boeck is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, K. De Boeck has authored 10 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Pathology and Forensic Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in K. De Boeck's work include Vitamin K Research Studies (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Biomedical Research and Pathophysiology (2 papers). K. De Boeck is often cited by papers focused on Vitamin K Research Studies (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Biomedical Research and Pathophysiology (2 papers). K. De Boeck collaborates with scholars based in Belgium and United States. K. De Boeck's co-authors include Rogier Caluwé, An S. De Vriese, Dirk De Bacquer, Bruno Van Vlem, Joost Delanote, Francis Verbeke, Didier De Surgeloose, Ellen Dilissen, Jan Ceuppens and Isabelle Meyts and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

K. De Boeck

10 papers receiving 444 citations

Peers

Countries citing papers authored by K. De Boeck

Since Specialization

Citations

This map shows the geographic impact of K. De Boeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. De Boeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. De Boeck more than expected).

Fields of papers citing papers by K. De Boeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. De Boeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. De Boeck. The network helps show where K. De Boeck may publish in the future.

Co-authorship network of co-authors of K. De Boeck

This figure shows the co-authorship network connecting the top 25 collaborators of K. De Boeck. A scholar is included among the top collaborators of K. De Boeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. De Boeck. K. De Boeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial 2021 ·Journal of the American Society of Nephrology ·An S. De Vriese, Rogier Caluwé, (unknown), K. De Boeck, Dirk De Bacquer	107
2	Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study 2019 ·Journal of the American Society of Nephrology ·An S. De Vriese, Rogier Caluwé, (unknown), Dirk De Bacquer, K. De Boeck, Joost Delanote, Didier De Surgeloose, (unknown), Bruno Van Vlem, Francis Verbeke	125
3	The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials 2015 ·Clinical Kidney Journal ·Rogier Caluwé, (unknown), K. De Boeck, An S. De Vriese	70
4	Fabry disease in a patient with Turner syndrome 2009 ·Journal of Inherited Metabolic Disease ·Raf Brouns, François Eyskens, K. De Boeck, Chantal Ceuterick‐de Groote, Marleen Van den Broeck, Christine Van Broeckhoven, Peter Paul De Deyn	3
5	Type III IFN‐λ mRNA expression in sputum of adult and school‐aged asthmatics 2008 ·Clinical & Experimental Allergy ·Dominique Bullens, Ann Decraene, Ellen Dilissen, Isabelle Meyts, K. De Boeck, Lieven Dupont, Jan Ceuppens	50
6	Two-tier approach for the detection of alpha-galactosidase A deficiency in a predominantly female haemodialysis population 2007 ·Nephrology Dialysis Transplantation ·Wim Terryn, Bruce Poppe, Birgitte Wuyts, Kathleen Claes, Bart Maes, Dierik Verbeelen, Raymond Vanholder, K. De Boeck, Norbert Lameire, A. De Paepe, Gert De Schoenmakere	30
7	Efficacy and Safety of Oral Fludarabine Phosphate in Previously Untreated Patients With Chronic Lymphocytic Leukemia 2004 ·Journal of Clinical Oncology ·Jean François Rossi, Ambro van Hoof, K. De Boeck, S.A. Johnson, Dominique Bron, C. Foussard, Tim Lister, Christian Berthou, (unknown), Timothy J. Littlewood, Robert Marcus, Éric Deconinck, Marco Montillo, (unknown), Susan M. Tollerfield	36
8	Response to bronchodilators in clinically stable 1-year-old patients with bronchopulmonary dysplasia 1998 ·European Journal of Pediatrics ·K. De Boeck, Johan Smith, Stefaan Van Lierde, H. Devlieger	21
9	Comparative Study of Cefetamet Pivoxil and Penicillin V in the Treatment of Group A Beta-Hemolytic Streptococcal Pharyngitis 1992 ·Chemotherapy ·(unknown), Denis Piérard, Peter Vandenberghe, K. De Boeck	9
10	Author Index / Subject Index 1992 ·Chemotherapy ·Ron Dagan, J. Pukander, (unknown), Markku Sipilä, (unknown), (unknown), (unknown), Christophe Delacourt, (unknown), (unknown), Denis Piérard, Peter Vandenberghe, K. De Boeck, George A. Syrogiannopoulos, D.J. Edwards, K. Stoeckel, W. Cullmann	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact